Home » Newsletters » BioWorld Asia

BioWorld Asia

Feb. 17, 1999

View Archived Issues

PowderJect, Ares-Serono Enter $100M Deal For Dry Vaccines

British Biotech's Marimastat Fails In Pivotal Cancer Study

Genetically Modified Milk Could Be Next On Shelves

Biota's Influenza Drug Wins Pair Of Approvals

Genset Reports Highest Quarterly Loss Of Year

European Parliament Calls For Amended GMO Rules

Cerep Revenues Hit Slump After Several Contracts End

EU Backs Biosafety Protocol, Warns Of 'Extreme Positions'

GMO Soya Crops Will Outdo Other Variety, Says Professor

Trinity Biotech's EPS Up 67 Percent For Year

Virax Shares Valued Higher After Patents

Monsanto's GMO Cotton Plan Still Stymied By EU

Today's news in brief
BioWorld
BioWorld briefs for Jan. 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 13, 2025
Caplyta star shines as J&J takes Intra-Cellular in $14.6B deal
BioWorld
The J.P. Morgan (JPM) Healthcare Conference in San Francisco kicked off with a resounding bang as Johnson & Johnson (J&J) disclosed plans to acquire...
Proteomics study explores how protein changes influence disease
BioWorld Science
Fourteen global pharma companies are getting together to conduct the largest proteomics study to date, analyzing 600,000 blood samples held in the UK Biobank to...
Type 1 diabetes breakthrough? Sana threads key ‘islet,’ SC-451 to advance
BioWorld
Sana Biotechnology Inc. CEO Steve Harr said “cool and transformative science” led to his firm’s latest strides in type 1 diabetes, and the “very generalizable...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.